Literature DB >> 22006425

Continuing the search for MR imaging biomarkers for MGMT promoter methylation status: conventional and perfusion MRI revisited.

Ajay Gupta, Antonio M P Omuro, Akash D Shah, Jerome J Graber, Weiji Shi, Zhigang Zhang, Robert J Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22006425      PMCID： PMC4724213          DOI： 10.1007/s00234-011-0970-z

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


× No keyword cloud information.
  5 in total

1.  Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging.

Authors:  Won-Jin Moon; Jin Woo Choi; Hong Gee Roh; So Dug Lim; Young-Cho Koh
Journal:  Neuroradiology       Date:  2011-08-11       Impact factor: 2.804

2.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

3.  Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.

Authors:  Marica Eoli; Francesca Menghi; Maria Grazia Bruzzone; Tiziana De Simone; Lorella Valletta; Bianca Pollo; Lorena Bissola; Antonio Silvani; Donatella Bianchessi; Ludovico D'Incerti; Graziella Filippini; Giovanni Broggi; Amerigo Boiardi; Gaetano Finocchiaro
Journal:  Clin Cancer Res       Date:  2007-05-01       Impact factor: 12.531

4.  MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.

Authors:  Alba A Brandes; Enrico Franceschi; Alicia Tosoni; Valeria Blatt; Annalisa Pession; Giovanni Tallini; Roberta Bertorelle; Stefania Bartolini; Fabio Calbucci; Alvaro Andreoli; Giampiero Frezza; Marco Leonardi; Federica Spagnolli; Mario Ermani
Journal:  J Clin Oncol       Date:  2008-05-01       Impact factor: 44.544

5.  An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.

Authors:  Sylvia Drabycz; Gloria Roldán; Paula de Robles; Daniel Adler; John B McIntyre; Anthony M Magliocco; J Gregory Cairncross; J Ross Mitchell
Journal:  Neuroimage       Date:  2009-09-28       Impact factor: 6.556
  5 in total
  8 in total

1.  Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status.

Authors:  Panagiotis Korfiatis; Timothy L Kline; Daniel H Lachance; Ian F Parney; Jan C Buckner; Bradley J Erickson
Journal:  J Digit Imaging       Date:  2017-10       Impact factor: 4.056

2.  Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.

Authors:  Shanshan Jiang; Qihong Rui; Yu Wang; Hye-Young Heo; Tianyu Zou; Hao Yu; Yi Zhang; Xianlong Wang; Yongxing Du; Xinrui Wen; Fangyao Chen; Jihong Wang; Charles G Eberhart; Jinyuan Zhou; Zhibo Wen
Journal:  Eur Radiol       Date:  2017-12-12       Impact factor: 5.315

3.  MRI to MGMT: predicting methylation status in glioblastoma patients using convolutional recurrent neural networks.

Authors:  Lichy Han; Maulik R Kamdar
Journal:  Pac Symp Biocomput       Date:  2018

4.  Potential role of preoperative conventional MRI including diffusion measurements in assessing epidermal growth factor receptor gene amplification status in patients with glioblastoma.

Authors:  R J Young; A Gupta; A D Shah; J J Graber; A D Schweitzer; A Prager; W Shi; Z Zhang; J Huse; A M P Omuro
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

5.  MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas.

Authors:  Panagiotis Korfiatis; Timothy L Kline; Lucie Coufalova; Daniel H Lachance; Ian F Parney; Rickey E Carter; Jan C Buckner; Bradley J Erickson
Journal:  Med Phys       Date:  2016-06       Impact factor: 4.071

6.  Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.

Authors:  Yu Han; Lin-Feng Yan; Xi-Bin Wang; Ying-Zhi Sun; Xin Zhang; Zhi-Cheng Liu; Hai-Yan Nan; Yu-Chuan Hu; Yang Yang; Jin Zhang; Ying Yu; Qian Sun; Qiang Tian; Bo Hu; Gang Xiao; Wen Wang; Guang-Bin Cui
Journal:  BMC Cancer       Date:  2018-02-21       Impact factor: 4.430

7.  Validation of MRI-Based Models to Predict MGMT Promoter Methylation in Gliomas: BraTS 2021 Radiogenomics Challenge.

Authors:  Byung-Hoon Kim; Hyeonhoon Lee; Kyu Sung Choi; Ju Gang Nam; Chul-Kee Park; Sung-Hye Park; Jin Wook Chung; Seung Hong Choi
Journal:  Cancers (Basel)       Date:  2022-10-03       Impact factor: 6.575

8.  Radiological model based on the standard magnetic resonance sequences for detecting methylguanine methyltransferase methylation in glioma using texture analysis.

Authors:  Wei-Yuan Huang; Ling-Hua Wen; Gang Wu; Pei-Pei Pang; Richard Ogbuji; Chao-Cai Zhang; Feng Chen; Jian-Nong Zhao
Journal:  Cancer Sci       Date:  2021-05-07       Impact factor: 6.716
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.